The p16/miR-217/EGR1 pathway modulates age-related tenogenic differentiation in tendon stem/progenitor cells

Weifeng Han, Bing Wang, Junpeng Liu, and Lei Chen

Department of Orthopaedics, Beijing Tian Tan Hospital, Capital Medical University, Beijing 100050, China

Acta Biochim Biophys Sin 2017, 49: 1015–1021; doi: 10.1093/abbs/gmx104

Previous studies have shown that the differentiation potential declines with the age of progenitor cells and is linked to altered levels of senescence markers. The purpose of this study was to test whether senescence marker p16 affects age-related tenogenic differentiation in tendon stem/progenitor cells (TSPCs). Young and aged TSPCs were isolated from young/healthy and aged/degenerated human Achilles tendons, respectively. Cellular aging and capacity for tenogenic differentiation were examined. The results showed that the tenogenic differentiation capacity of TSPCs significantly decreases with advancing age. TSPCs from elderly donors showed upregulation of senescence-associated β-galactosidase and p16 and concurrently a decrease in Type I collagen concentration and in the expressions of tendon-related markers: Scx, Tnmd, Bgn, Dcn, Col1, and Col3. Overexpression of p16 significantly inhibited tenogenic differentiation of young TSPCs. Analysis of the mechanism revealed that this effect is mediated by microRNA-217 and its target EGR1. These results indicated that p16 inhibits tenogenic differentiation of TSPCs via microRNA signaling pathways, which may serve as a potential target for the prevention or treatment in the future.

p16 transforms the phenotype of young TSPCs to aged TSPCs

阅读原文: http://www.abbs.org.cn/arts.asp?id=4227

获取全文: abbs@sibs.ac.cn

相关论文:

1 Biologics for tendon repair

2 Tendon injury: from biology to tendon repair

3 Harnessing endogenous stem/progenitor cells for tendon regeneration

4 The past, present and future in scaffold-based tendon treatments

5 Progress in cell-based therapies for tendon repair

6 Tendon Basic Science: Development, Repair, Regeneration, and Healing

7 Cell-material interactions in tendon tissue engineering

8 Mesenchymal stem cells for tendon healing: what is on the horizon?